How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
MAXIMUS, Inc. MMS | 0.00 |
- In August 2026, Maximus, Inc. reported its fiscal third quarter results, showing quarterly revenue of US$1,278.97 million and net income of US$103.59 million, and updated full-year 2026 guidance to revenue of US$5.2–US$5.35 billion and net income of US$376–US$392 million with diluted EPS of US$6.94–US$7.24.
- Alongside these results, management reiterated its focus on disciplined acquisitions and share repurchases within a target net debt ratio of 2x–3x, emphasizing deals that expand capabilities and customer access while seeking revenue synergies that exceed the company’s cost of capital.
- We’ll now examine how Maximus’ reaffirmed focus on disciplined acquisitions and capital deployment may reshape the previously outlined investment narrative.
Find 53 companies with promising cash flow potential yet trading below their fair value.
Maximus Investment Narrative Recap
To own Maximus, you need to believe that governments will keep outsourcing complex health and human services, and that Maximus can steadily improve margins through technology and disciplined capital deployment. The latest guidance and Q3 results do not materially change that near term story, but they do keep attention on the key short term catalyst of new legislation driven work against the persistent risk of volume swings and budget pressure on large U.S. contracts.
The most relevant update here is management’s reiterated capital allocation framework alongside reaffirmed 2026 guidance for revenue of US$5.2–US$5.35 billion and net income of US$376–US$392 million. That combination links the acquisition focus directly to the core catalysts around technology enabled services and margin efficiency, while the commitment to stay within a 2x–3x net debt range helps frame how aggressively Maximus can pursue deals or buybacks if contract volumes or budgets move against it.
Yet behind that apparent stability, investors should be aware that contract renewal risk and budget constraints could still...
Maximus' narrative projects $6.0 billion revenue and $458.8 million earnings by 2029. This requires 4.7% yearly revenue growth and about an $87.9 million earnings increase from $370.9 million today.
Uncover how Maximus' forecasts yield a $100.00 fair value, a 84% upside to its current price.
Exploring Other Perspectives
Some analysts are far more optimistic, assuming revenue of about US$5.9 billion and earnings near US$493 million by 2029, while others stress automation and contract renewal risks, so you should expect these narratives to evolve as this latest acquisition and capital deployment focus is absorbed.
Explore 3 other fair value estimates on Maximus - why the stock might be worth over 2x more than the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Maximus research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Maximus research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Maximus' overall financial health at a glance.
Curious About Other Options?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
- The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
